Active Ingredient(s): Romiplostim
FDA Approved: * August 22, 2008
Pharm Company: * AMGEN
Category: Blood Clotting (Hemostasis)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nplate Overview

Romiplostim, sold under the brand name Nplate among others, is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Contents 1 Indications and Marketing 2 Treatment regimen 3 Clinical efficacy 4 Side-effects 5 References 6 External links Indications and Marketing The drug was developed by Amgen through a restricted usage program called NEXUS.[1] During development and clinical trials the drug was called AMG531. Romiplostim is indicat...

Read more Nplate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nplate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1mcg, 250mcg/0.5ml + 500mcg/1ml.
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nplate: (3 results)

Sorted by National Drug Code
  • 55513-221 Nplate 250 ug/.5ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc
  • 55513-222 Nplate 500 ug/ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc
  • 55513-223 Nplate 125 mg/.25ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Amgen Inc

Other drugs which contain Romiplostim or a similar ingredient: (1 result)

Related Nplate Topics:

side effects...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA